The increased expression of PDCD1LG2 in pancreatic cancer is related to higher tumor grade, poorer prognosis, higher clinical stage, and worse molecular subtype and FAK promotes immune escape of pancreatic cancer through regulating PDCD1LG2 (42). This evidence concerns the gene PTK2 and pancreatic neoplasm.